EGIS-12233

Chemical compound From Wikipedia, the free encyclopedia

EGIS-12,233 is a drug with applications in scientific research, acting as a potent and selective antagonist for both the 5-HT6 and 5-HT7 serotonin receptor subtypes, with good selectivity over other receptors.[1] It has been shown to increase dopamine release in cochlear tissue, suggesting a role for the 5-HT6 and 5-HT7 receptors in regulation of the hearing system.[2]

ATC code
  • none
Quick facts Clinical data, ATC code ...
EGIS-12233
Clinical data
ATC code
  • none
Identifiers
  • 5,7-dichloro-3-[4-[4-(4-chlorophenyl)piperazin-1-yl]butyl]-3-ethyl-indolin-2-one
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H28Cl3N3O
Molar mass480.86 g·mol−1
3D model (JSmol)
  • c3cc(Cl)ccc3N4CCN(CC4)CCCCC1(CC)c2cc(Cl)cc(Cl)c2NC1=O
  • InChI=1S/C24H28Cl3N3O/c1-2-24(20-15-18(26)16-21(27)22(20)28-23(24)31)9-3-4-10-29-11-13-30(14-12-29)19-7-5-17(25)6-8-19/h5-8,15-16H,2-4,9-14H2,1H3,(H,28,31)
  • Key:NOWFIMHNXPZVSK-UHFFFAOYSA-N
  (verify)
Close

References

Related Articles

Wikiwand AI